Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Hyperimmunoglobulin E syndrome in two siblings

    Abdulmohti Hawilo, Ines Zaraa, Sondes Trojjet, Hella Zribi, Rym Cheikh Rouhou, Dalenda El Euch, Mourad Mokni, Amel Ben Osman
    e41
    28-11-2011
    https://doi.org/10.4081/dr.2011.e41
    1370
    PDF: 587
    HTML: 513
  • 12 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, US; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, US; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, CA; 5Chang Gung University College of Medicine, Taoyuan, TW; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JP; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, DE; 8Department of Dermatology and Population Health Sciences, King’s College London, London, UK; 9Ada West Dermatology, St Luke's Children's Hospital, Idaho, US; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney AU; 11Eli Lilly and Company, Indianapolis, Indiana,US; 12Almirall R&D, S.A., Barcelona, ES; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, US

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11079
    244
    PDF: 78
  • Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma

    Yukari Matsumoto, Takeshi Fukumoto, Wakako Takahashi, Chikako Nishigori
    29-12-2022
    https://doi.org/10.4081/dr.2023.9617
    901
    PDF: 469
    HTML: 52
  • A case of human Dirofilaria repens in Rome, Italy: a clinical and radiological challenge

    Irene Campana, Luca Fania, Tonia Samela, Lara Campana, Viola Zecchi, Francesca Ricci, Damiano Abeni
    02-08-2022
    https://doi.org/10.4081/dr.2022.9354
    2055
    PDF: 554
    HTML: 26
  • Serial case reports: Pregnancy with Lucio’s phenomenon of leprosy in dr. Soetomo hospital, Surabaya

    Nareswari I. Cininta, M.I.A Akbar, Rozi A. Aryananda, Khanisyah E. Gumilar, Manggala Pascawardhana, Budi Wicaksono, E. Ernawati, Agus Sulistyono, A. Aditiawarman, Hermanto T. Joewono, M.N. Abdullah, Erry G. Dachlan
    01-04-2019
    https://doi.org/10.4081/dr.2019.8097
    1881
    PDF: 933
  • Face mask-induced skin changes: a new common phenomenon during the coronavirus disease 2019 pandemic

    Abrar E. Bukhari, Alhanouf A. Bin Dakhil, Abdulrhman A. Albrkheel, Malak M. Almutlq, Omar K. Alolayan, Mohammed A. Alqahtani, Fahad S. Alsubaie, Dana S. Alessa, Fajer M. Alzamil
    07-07-2022
    https://doi.org/10.4081/dr.2022.9526
    2136
    PDF: 575
    HTML: 47
  • An unusual case of Lyme borreliosis: can we miss it?

    Antigona Begolli Gerqari, Mybera Ferizi, Sadije Halimi, Albina Ponosheci, Arjeta Zogaj Berisha, Idriz Gerqari
    29-08-2019
    https://doi.org/10.4081/dr.2019.8021
    1333
    PDF: 810
    HTML: 34
  • 26 | CONCOMITANT THERAPY WITH IXEKIZUMAB PLUS TIRZEPATIDE IN ADULTS WITH PSORIATIC ARTHRITIS AND OVERWEIGHT OR OBESITY DEMONSTRATED SUPERIOR DISEASE CONTROL COMPARED TO IXEKIZUMAB ALONE: RESULTS FROM THE PH3B TOGETHER-PSA TRIAL E. Filippi1, J. F. Merola2, P. Mease3, A. Kivitz4, N. Sattar5, L. C. Coates6, C. E. Kartman7, P. Fischer7, L. Sun7, A. Cardoso7, M. C. Genovese7, A. Ogdie8 | 1Eli Lilly Italia S.p.A, Florence, Italy; 2Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; 3Providence Swedish Medical Center, Seattle, WA, USA; 4Altoona Center for Clinical Research, Duncansville, PA, USA; 5School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; 6Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; 7Eli Lilly and Company, Indianapolis, IN, USA; 8Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11088
    147
    PDF: 60
  • Dermoscopy of kaposiform hemangioendothelioma: a case report

    Filomena Barbato, Maria Maddalena Nicoletti, Gaetano Licata, Eugenia Veronica Di Brizzi, Giuseppe Argenziano, Caterina Mariarosaria Giorgio
    11-07-2025
    https://doi.org/10.4081/dr.2025.10363
    445
    PDF: 344
    HTML: 34
  • Diverse clinical manifestations of acquired vulvar lymphangioma: a report of five cases in Vietnamese women

    Tho Thi Thanh Nguyen, Anh Nguyen Ngoc Hoang, Thu Nguyen Anh Luu, Thuy Thi Phan Nguyen, Em Van Loi Doan, Tu Nguyen Anh Tran, Hao Trong Nguyen
    29-01-2024
    https://doi.org/10.4081/dr.2024.9888
    960
    PDF: 498
    HTML: 27
  • A case of coxsackievirus A16-induced hand-foot-mouth disease mimicking erythema multiforme

    Shigeru Koizumi, Kazuhiro Inafuku
    25-08-2023
    https://doi.org/10.4081/dr.2023.9801
    627
    PDF: 470
    HTML: 56
  • Human monkeypox coinfection with syphilis in an immunocompromised patient

    Irvin Ordoñez-González, Berenice López-Zamora, Gabriela Medina, Geraldine Vanessa Reyes-Navarro, Alberto Ordinola Navarro, María Pilar Cruz-Domínguez, Olga Vera-Lastra, Miguel Ángel Saavedra
    27-10-2022
    https://doi.org/10.4081/dr.2022.9591
    1418
    PDF: 632
    HTML: 134
  • Slow responder against methotrexate 50 mg intramuscular in severe psoriatic patients: A case series

    Niken Kusumaningrum, Danar Wicaksono, Dwi Retno Adi Winarni, Yohanes Widodo Wirohadidjojo, Sunardi Radiono
    01-04-2019
    https://doi.org/10.4081/dr.2019.8080
    1127
    PDF: 479
  • Subclinical onychomycosis in patients with type II diabetes

    Amira Elbendary, Amira El Tawdy, Naglaa Zaki, Mostafa Alfishawy, Amr Rateb
    17-12-2015
    https://doi.org/10.4081/dr.2015.6099
    1993
    PDF: 925
    HTML: 417
  • A case of post-inflammatory warty dyskeratoma of the chest: Other dermoscopic features

    Vito Ingordo, Gerardo Ferrara, Irene Ingordo, Giuseppe Argenziano
    22-10-2020
    https://doi.org/10.4081/dr.2020.8791
    1398
    PDF: 529
    Appendix: 195
    HTML: 77
  • 67 | LEBRIKIZUMAB FOR PAEDIATRIC PATIENTS AGED ≥6 MONTHS WITH MODERATE-TO-SEVERE AD: PHASE 3 ADORABLE-1 WEEK-16 RESULTS L. Stingeni1, L. Eichenfield2, J. Ornelas3, V. Prajapati4, C. Yang5, A. Tanaka6, S. Weidinger7, C. Flohr8, E. Swanson9, L. Martin10, S. Daveiga11, R. Gontijo Lima11, H. Elmaraghy11, E. Pierce11, P. Sen11, G. Gallo11, M. Piruzeli11, A. Larkin11, M. Grau12, Y. Mihaylov12, A. Paller13 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Departments of Dermatology and Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA; 3Department of Dermatology, Integrative Skin Science and Research, Sacramento, California, USA; 4Dermatology Research Institute, Skin Health & Wellness Centre, Probity Medical Research, and University of Calgary, Calgary, Canada; 5Chang Gung University College of Medicine, Taoyuan, Taiwan; 6Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; 7Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Lübeck, Germany; 8Department of Dermatology and Population Health Sciences, King’s College London, UK; 9Ada West Dermatology, St Luke’s Children’s Hospital Idaho, USA; 10School of Clinical Medicine, UNSW Sydney & Dermatology Department, Sydney Children’s Hospital, Sydney, Australia; 11Eli Lilly and Company, Indianapolis, Indiana, USA; 12Almirall R&D, S.A., Barcelona, Spain; 13Dermatology and Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11114
    166
    PDF: 97
  • Efficacy and safety of risankizumab in patients with erythrodermic and sub-erythrodermic psoriasis: a case series

    Andrea D'Arino, Maria Concetta Fargnoli, Pasquale Frascione, Chiara Assorgi, Annunziata Dattola, Viviana Lora, Matteo Megna, Flavia Pigliacelli, Emanuele Vagnozzi, Diego Orsini
    30-07-2025
    https://doi.org/10.4081/dr.2025.10379
    623
    PDF: 452
    HTML: 15
  • Generalized bullous drug eruption triggered by ceftriaxone: a case report and literature overview

    Khuzama Alfalah, Khalid Nabil Nagshabandi, Hala Abdullah Almusa
    25-02-2025
    https://doi.org/10.4081/dr.2025.10208
    770
    PDF: 473
    HTML: 53
  • Pityriasis following COVID-19 vaccinations: a systematic review

    Laura Duzett, Guadalupe Mercado, Vasiliki Tasouli-Drakou, Alicia Kane, Alison Tam
    09-08-2023
    https://doi.org/10.4081/dr.2023.9742
    1414
    PDF: 789
    Supplementary Material: 168
    HTML: 86
  • Certolizumab to treat hidradenitis suppurativa

    Asem Shadid, Saud Alobaida, Yousef Binamer
    27-10-2022
    https://doi.org/10.4081/dr.2022.9566
    2010
    PDF: 766
    HTML: 56
  • The efficacy of a bioactive moisturizer in mitigating side effects of acne therapies: a randomized, investigator-blind, split-face trial

    Jidapa Triwatcharikorn, Supanee Techamontrikul, Natnicha Ngamdumrongkiat, Pawinee Rerknimitr
    27-03-2026
    https://doi.org/10.4081/dr.2026.10491
    986
    PDF: 866
    SUPPLEMENTARY MATERIAL: 70
  • The efficacy of vitamin D3 supplementation in increasing 25-hydroxyvitamin D levels in childhood vitiligo patients receiving 308-nm-excimer light phototherapy

    Reiva Farah Dwiyana, Pramita K.C. Nugrahaini, D.P. Larasati, Inne Arline Diana, Reti Hindritiani, Hendra Gunawan, Oki Suwarsa
    29-03-2019
    https://doi.org/10.4081/dr.2019.8049
    3165
    PDF: 695
  • Generalized mid dermal elastolysis

    Maria João Cruz, Ana Margarida Barros, Filomena Azevedo
    e52
    01-12-2011
    https://doi.org/10.4081/dr.2011.e52
    2624
    PDF: 1185
    HTML: 2528
  • Growth dynamics and cyclin expression in cutaneous T-cell lymphoma cell lines

    Edyta Biskup, Valentina Manfé, Maria Kamstrup, Robert Gniadecki
    e8
    06-05-2010
    https://doi.org/10.4081/dr.2010.e8
    1936
    PDF: 695
    HTML: 146
  • 11 | EFFICACY AND SAFETY OF LEBRIKIZUMAB IS MAINTAINED UP TO 4 YEARS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: FIRST YEAR OF ADLONG LONG-TERM EXTENSION TRIAL L. Stingeni1, S. Weidinger2, A. Irvine3, D. Thaçi4, J. Szepietowski5, T. Biedermann6, H. Agell7, Y. Mihaylov7, B. Kostov7, R. Coll7, W. Romero8, K. Reich9 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany; 3Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 4Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 5Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, Poland; 6Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany; 7Almirall S.A., Barcelona, Spain; 8Eli Lilly and Company, Indianapolis, IN, USA; 9Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11078
    141
    PDF: 85
426 - 450 of 460 items << < 16 17 18 19 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.